The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression
I. Ricklefs (Luebeck, Germany), L. Schäfer (Luebeck, Germany), N. Weissheimer (Luebeck, Germany), M. Weckmann (Luebeck, Germany), D. Thiele (Luebeck, Germany), I. König (Luebeck, Germany), E. Von Mutius (Munich, Germany), G. Hansen (Hanover, Germany), K. Rabe (Großhansdorf, Germany), M. Kopp (Luebeck, Germany)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Session: Novel mechanisms and management of paediatric asthma
Session type: E-poster session
Number: 1220
Disease area: Airway diseases, Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Ricklefs (Luebeck, Germany), L. Schäfer (Luebeck, Germany), N. Weissheimer (Luebeck, Germany), M. Weckmann (Luebeck, Germany), D. Thiele (Luebeck, Germany), I. König (Luebeck, Germany), E. Von Mutius (Munich, Germany), G. Hansen (Hanover, Germany), K. Rabe (Großhansdorf, Germany), M. Kopp (Luebeck, Germany). The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression. 1220
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: